Press Releases

Date Title and Summary Additional Formats
Toggle Summary Concert Pharmaceuticals Announces Positive Results from Phase I Clinical Study of CTP-347; First Clinical Demonstration of Concert's Technology Platform
First Clinical Demonstration of Concert’s Technology Platform
View HTML
Toggle Summary Concert Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference on March 16, 2009
Concert Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference on March 16, 2009 LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today that Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present at the Cowen and Company 29th
View HTML
Toggle Summary Concert Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on Monday, January 12
Concert Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on Monday, January 12 LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today that it will be presenting at the 27th Annual J.P. Morgan Healthcare Conference, being held at the Westin St.
View HTML
Toggle Summary Concert Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
Concert Pharmaceuticals to Present at the Piper Jaffray Health Care Conference LEXINGTON, MA -- Concert Pharmaceuticals, Inc. announced today that it will be presenting at the 20th Annual Piper Jaffray Health Care Conference, being held at The New York Palace in New York City.
View HTML
Toggle Summary Concert Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
Concert Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference LEXINGTON, MA -- Concert Pharmaceuticals, Inc. announced today that it will be presenting at the Oppenheimer 19th Annual Healthcare Conference, being held at the Waldorf-Astoria Hotel in New York City.
View HTML
Toggle Summary Concert Pharmaceuticals Announces Preclinical Results Suggesting Potential for Once Daily Dosing of Novel Oxazolidinone Antibiotic; Findings Presented at ICAAC/IDSA
Findings Presented at ICAAC/IDSA
View HTML
Toggle Summary Concert Pharmaceuticals to Present at First Annual Boston Biotech R&D Conference
Concert Pharmaceuticals to Present at First Annual Boston Biotech R&D Conference Lexington, MA – Concert Pharmaceuticals, Inc. today announced that it will be presenting at the 2008 Boston Biotech R&D Conference being held at Harvard Medical School in Cambridge, Massachusetts.  Roger Tung, Ph.D.,
View HTML
Toggle Summary Steven Bernitz Joins Concert Pharmaceuticals as Chief Business Officer
Steven Bernitz Joins Concert Pharmaceuticals as Chief Business Officer Lexington, MA – Concert Pharmaceuticals, Inc. today announced that Steven B. Bernitz has joined the company as its Senior Vice President and Chief Business Officer.  In this role, he will be a member of Concert’s executive
View HTML
Toggle Summary Concert Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
Concert Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference Lexington, MA - Concert Pharmaceuticals, Inc. announced today that it will be presenting at the Third Annual JMP Securities Healthcare Focus Conference, being held at the Le Parker Meridien in New York City.
View HTML
Toggle Summary Concert Pharmaceuticals Presents Preclinical Results Supporting Co-Administration of CTP-347 and Tamoxifen; Results Presented at the North American Menopause Society's 2008 Annual Meeting
Concert Pharmaceuticals Presents Preclinical Results Supporting Co-Administration of CTP-347 and Tamoxifen; Results Presented at the North American Menopause Society's 2008 Annual Meeting Results Presented at the North American Menopause Society’s 2008 Annual Meeting Orlando, FL – Concert
View HTML